| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/08/2003 | EP1272488A2 Tri-aryl-substituted-ethane pde4 inhibitors |
| 01/08/2003 | EP1272487A1 Bicyclic heteroaryl compounds as inhibitors of the interaction between the integrin alpha4beta1 receptor and vcam-1 and/or fibronectin |
| 01/08/2003 | EP1272484A2 Benzoamide piperidine compounds as substance p antagonists |
| 01/08/2003 | EP1272481A1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 01/08/2003 | EP1272468A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 01/08/2003 | EP1272455A1 Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 01/08/2003 | EP1272225A2 Lipid-based systems for targeting diagnostic agents |
| 01/08/2003 | EP1272205A1 Sialoadhesin factor-2 antibodies |
| 01/08/2003 | EP1272204A2 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
| 01/08/2003 | EP1272201A2 Use of compatible solutes as substances having free radical scavenging properties |
| 01/08/2003 | EP1272200A1 Divided dose therapies with vascular damaging activity |
| 01/08/2003 | EP1272186A1 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 01/08/2003 | EP1272185A2 Use of quinazoline derivatives as angiogenesis inhibitors |
| 01/08/2003 | EP1272183A1 Methods and compositions useful in enhancing oxygen delivery to cells |
| 01/08/2003 | EP1272175A2 Il-8 receptor antagonists |
| 01/08/2003 | EP1272169A2 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 01/08/2003 | EP1272168A2 Small organic molecule regulators of cell proliferation |
| 01/08/2003 | EP1272161A2 Lipid-based drug delivery systems against parasitic infections |
| 01/08/2003 | EP1272160A2 Lipid-based drug delivery systems for topical application |
| 01/08/2003 | EP1272156A1 Use of alcohol dehydrogenase inhibitors for cosmetic treatment of keratinous materials |
| 01/08/2003 | EP1272155A1 Use of natural substances in the production of cosmetic preparations |
| 01/08/2003 | EP1272154A1 Composition for improving skin lipid barrier function |
| 01/08/2003 | EP1272144A2 New cosmetic, personal care, cleaning agent, and nutritional supplement compositions comprising bioactive glass and methods of making and using the same |
| 01/08/2003 | EP1123276B1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 01/08/2003 | EP1119355B1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 01/08/2003 | EP1098651B1 Novel urokinase inhibitors |
| 01/08/2003 | EP1077945B1 Isoquinolines as urokinase inhibitors |
| 01/08/2003 | EP1066061A4 Use of scatter factor to enhance angiogenesis |
| 01/08/2003 | EP1064008B1 Use of at least one protein extract of the moringa genus plant seeds and corresponding cosmetic and/or pharmacological composition |
| 01/08/2003 | EP1021161B1 Use of ellagic acid and its derivatives in cosmetics and dermatology |
| 01/08/2003 | EP1001677A4 A novel method for treating epidermal or dermal conditions |
| 01/08/2003 | EP0859622B1 Extracts of shark cartilage |
| 01/08/2003 | EP0822803B1 Cosmetic agent with an ilex resin content, process for extraction of ilex resin and ilex resin obtained thereby |
| 01/08/2003 | EP0796107B1 Sunscreen-wound healing composition |
| 01/08/2003 | EP0646012B1 WOUND HEALING AND TREATMENT OF FIBROTIC DISORDERS BY TGFbeta-3 |
| 01/08/2003 | CN1390222A Imidazole compounds used as phosphodiesterase VII inhibitors |
| 01/08/2003 | CN1390220A Kinase inhibitors as therapeutic agents |
| 01/08/2003 | CN1390219A Pyrazolopyrimidines as therapeutic agents |
| 01/08/2003 | CN1390218A New active marine alkaloids |
| 01/08/2003 | CN1390215A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 01/08/2003 | CN1390211A Benzoic ester comprising ethoxyl acyl piperazine substituted oxazolidone compound |
| 01/08/2003 | CN1390137A A Blocking monoclonal antibody to VLA-1 and its use for the treatment of inflammatory disorders |
| 01/08/2003 | CN1390135A Topical treatment of streptococcal infections |
| 01/08/2003 | CN1390132A Use of pegylated interferon alpha in melanoma therapy |
| 01/08/2003 | CN1390118A Dextrose and insulin fluid formulation for intravenous infusion |
| 01/08/2003 | CN1389267A Recipe and prepn. of medicine for treating diabetes and ulcer |
| 01/08/2003 | CN1389266A Ointment for treating burns and scalds and its prepn. |
| 01/08/2003 | CN1389262A Externally applied medicine for stopping itching, relieving pain and eliminating swelling |
| 01/08/2003 | CN1389261A Externally applied Chinese medicine for treating trauma and its prepn. |
| 01/08/2003 | CN1389259A Psoriasis-treating ointment and its compounding process |
| 01/08/2003 | CN1389241A Composite medicine for treating hircus, tinea and external piles |
| 01/08/2003 | CN1389238A Skin care cream |
| 01/08/2003 | CN1389231A Composite Chinese medicine for treating venereal disease and dermatosis and its prepn. |
| 01/08/2003 | CN1389226A Arborescent aloe granule |
| 01/08/2003 | CN1389215A Hongbing ointment as one kind of locally administrated prepn. |
| 01/08/2003 | CN1389211A Puerarin injection and its prepn. process |
| 01/08/2003 | CN1389203A Method for treating hair-dropping using thyromimetic compound |
| 01/08/2003 | CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
| 01/08/2003 | CN1098097C External-use ointment for treating burns and scalds |
| 01/08/2003 | CN1098086C Mastic for treating acne |
| 01/08/2003 | CN1098071C Transdermal device for delivery of flurbiprofen |
| 01/08/2003 | CN1098069C Transdermal device for delivery of flurbiprofen |
| 01/08/2003 | CN1098063C Sun screening agent and cosmetics containing it |
| 01/07/2003 | US6504028 Process for preparing benzoxazin-4-one polymer conjugates |
| 01/07/2003 | US6503930 Pyrazole derivatives as p38 kinase inhibitors |
| 01/07/2003 | US6503908 Pharmaceutically active compounds |
| 01/07/2003 | US6503905 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 01/07/2003 | US6503713 Methods for identifying RNA binding compounds |
| 01/07/2003 | US6503542 Herbal compositions for treating immunological disorders |
| 01/07/2003 | US6503539 Matrix protein compositions for wound healing |
| 01/07/2003 | US6503494 Composition comprising silicone polymer containing non-silicone backbone and at least one thickening polymer or copolymer of (meth) crylamide or of a (meth) acrylamide derivative |
| 01/07/2003 | CA2220923C Process of high purity albumin production |
| 01/07/2003 | CA2210365C New derivative of kojic acid and its use as a depigmenting agent |
| 01/07/2003 | CA2139253C Skin external agent |
| 01/06/2003 | CA2392187A1 Combination preparation for the therapy of immunological diseases |
| 01/05/2003 | CA2390181A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000864A2 Nucleic acid-associated proteins |
| 01/03/2003 | WO2003000844A2 Protein modification and maintenance molecules |
| 01/03/2003 | WO2003000727A2 Atopy |
| 01/03/2003 | WO2003000699A1 Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
| 01/03/2003 | WO2003000695A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 01/03/2003 | WO2003000694A1 6-phenyldihydropyrrolopyrimidinedione derivatives |
| 01/03/2003 | WO2003000688A1 Azaindoles |
| 01/03/2003 | WO2003000687A1 Tyrosine kinase inhibitors |
| 01/03/2003 | WO2003000684A1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | WO2003000678A1 Cyanoanthranilamide derivatives and the use thereof as medicaments |
| 01/03/2003 | WO2003000671A1 Naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/03/2003 | WO2003000668A1 Oxa(thia)zolidine compounds, process for preparation thereof and anti-inflammatory agents |
| 01/03/2003 | WO2003000653A1 Substituted n-acyl aniline derivatives, production and use thereof as medicaments |
| 01/03/2003 | WO2003000634A1 Vitamin d receptor antagonists and related compositions and methods of use |
| 01/03/2003 | WO2003000323A1 Safety shield system for prefilled syringes |
| 01/03/2003 | WO2003000322A1 Safety shield system for prefilled syringes |
| 01/03/2003 | WO2003000286A1 Remedies for eosinophilic diseases |
| 01/03/2003 | WO2003000259A1 Topical application of thiazolyl amides |
| 01/03/2003 | WO2003000243A1 Antimicrobial nanoemulsion compositions and methods |
| 01/03/2003 | WO2003000221A1 Use of quaternary polyammonium in the treatment of acne and cutaneous disorders linked to hyperseborrhoea |
| 01/03/2003 | WO2003000220A2 Use of 1,2-decandiol for combating germs causing body odour |
| 01/03/2003 | WO2003000209A1 Cosmetic or dermatological composition comprising n-acylaminoamide derivatives |
| 01/03/2003 | WO2003000208A1 Topical composition comprising a cytotoxic product |